Pharma Educator
Guest
Pharma Educator
Guest
StockTwit posters you completely misinterpreted the press release yesterday. Silenor is not "better" than Ambien. I suggest you re-read the press release, and analyze the clinical trial data when it becomes available. You apparently know nothing about wording of press releases in the pharma industry, and why looking at the data is important in understanding the truth. Hint: In case you are not intelligent enough to do this, I do not recommend investing in pharma companies as the major investors in Pernix understand this. Why do you think the stock price barely moved with this press release. It is NOT market manipulation. It is just a fluff press release to get all the uneducated inexperience investors all hyped (pumped).
Also, cool down on the buyout at anytime soon. All talks have broken down due to the anticipated horrible Q2 sales revenue that is now projected (worse than Q1).
Bash me all you want, but open your eyes.
Also, cool down on the buyout at anytime soon. All talks have broken down due to the anticipated horrible Q2 sales revenue that is now projected (worse than Q1).
Bash me all you want, but open your eyes.